Results 151 to 160 of about 69,836 (351)

Homografts in aortic position: does blood group incompatibility have an impact on patient outcomes? [PDF]

Interact Cardiovasc Thorac Surg, 2013
Vogt F, Böll BM, Boulesteix AL, Kilian E, Santarpino G, Reichart B, Schmitz C.   +6 more
europepmc   +1 more source

Changing perspectives on liver transplantation in 1988. [PDF]

, 1988
After liver transplantation for cancer, there is a high incidence of disease recurrence within 18 to 36 months for most tumors, although there are a small number of long-term survivors.
Gordon, RD, Starzl, TE
core  

The phenomenon of conversion of the donor-derived blood group to the patient’s original blood group after ABO-incompatible hematopoietic stem cell transplantation in a patient with Wiskott–Aldrich syndrome

, 2019
А. L. Khoreva, P. E. Trachtman, S. N. Kozlovskaya, K. V. Mitrakov, В. В. Бриллиантова, А. М. Попов, Dmitry Balashov   +6 more
openalex   +2 more sources

Vat Polymerization 3D Printing for Controlled Drug Release Applications

Advanced Materials Technologies, EarlyView.
ABSTRACT Vat polymerization (VP) 3D printing, a light‐based additive manufacturing technique, has emerged as a promising technique for fabricating complex drug delivery systems with high precision and spatial resolution. This layer‐by‐layer manufacturing process enables the creation of intricate geometries and customizable architectures, which are ...
Hafiz Busari, O. Thompson Mefford, M. Aaron Vaughn   +2 more
wiley   +1 more source

Production of scFvs as anti-ABO antibodies antagonist for prevention of hemolytic transfusion reactions resulting ABO blood groups incompatibility between donor and recipient

, 2016
Mozafar Mohammadi, Foroogh Nejatollahi, Peyman Bemani   +2 more
openalex   +1 more source

DOES G-6-PD DEFICIENCY INCREASE HEMOLYSIS IN ABO BLOOD GROUP INCOMPATIBLE NEONATES? † 1716 [PDF]

, 1996
Michael Kaplan, Hendrik J. Vreman, Cathy Hammerman, David K. Stevenson   +3 more
openalex   +1 more source

End‐to‐End Sensing Systems for Breast Cancer: From Wearables for Early Detection to Lab‐Based Diagnosis Chips

Advanced Materials Technologies, EarlyView.
This review explores advances in wearable and lab‐on‐chip technologies for breast cancer detection. Covering tactile, thermal, ultrasound, microwave, electrical impedance tomography, electrochemical, microelectromechanical, and optical systems, it highlights innovations in flexible electronics, nanomaterials, and machine learning.
Neshika Wijewardhane, Lyn I. Jones, Richard M. Martin, Helen Winter, Faezeh Arab Hassani   +4 more
wiley   +1 more source

Is the incidence of ABO blood groups incompatibility among Egyptian mothers and its relation to critical neonatal hyperbilirubinemia in healthy term and near-term newborns worth screening? Al Galaa Teaching Hospital experience

Egyptian Pediatric Association Gazette
Background Newborn infants with maternal-fetal ABO blood group system incompatibility face an increased risk of developing significant hyperbilirubinemia; early detection during the first 24 h and in subsequent days of life is of crucial importance.
Mona Sayed Aly Hassan Makhlouf, Mohammed Mourad Youssif, Sherif Mohamed Safwat Abdelbaky Abohleka, Marwa Radwan Abbass Shahine, Hoda Basheer Hussein Basheer   +4 more
doaj   +1 more source

Cap‐oPMN: Oral Inflammatory Load Quantification Using Capillary Microfluidics and Automated Image Processing

Advanced Materials Technologies, EarlyView.
ABSTRACT Quantifying oral polymorphonuclear neutrophils (oPMNs) is a clinically validated approach for assessing periodontal inflammation. However, current methods, such as manual hemocytometry and flow cytometry, are time‐consuming (>3 h), require invasive sampling, and depend on staining and complex instrumentation, making them unsuitable for point ...
Mohsen Hassani, Azam Zare, Fatemeh Soheili, S. M. Mahdi H. Daneshvar, Mahdi Amrollahi Biouki, Yasaman Tahernezhad, Chunxiang Sun, Michael Glogauer, Ebrahim Ghafar‐Zadeh, Amir Sanati‐Nezhad   +9 more
wiley   +1 more source

Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn. [PDF]

J Neonatal Perinatal Med, 2015
Calkins K, Roy D, Molchan L, Bradley L, Grogan T, Elashoff D, Walker V.   +6 more
europepmc   +1 more source